Michelle Afkhami, MD
Chief, Division of Molecular Pathology & Therapy Biomarkers; CLIA Lab Director, COH-Clinical Molecular Genomics and Cytogenomics Laboratory; Medical Director, Cytogenetics Laboratory and Clinical Molecular Diagnostic Laboratory; Director, Core Cytogenetics Laboratory, Beckman Research Institute
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Michelle Afkhami is the Chief of the Division of Molecular Pathology & Therapy Biomarkers and CLIA Lab Director at the City of Hope Inc, USA. She serves as the Medical Director for the Cytogenetics Laboratory and Clinical Molecular Diagnostic Laboratory, as well as the Director of the Core Cytogenetics Laboratory at the Beckman Research Institute. Her recent research focuses on the genomic landscape of hematological malignancies, HPV-related oropharyngeal carcinoma outcomes, and various tumor pathologies, including NUT carcinoma and myeloid neoplasms.
Articles (8)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Collaborators (2)
Barbara Fortini
Associate Professor
Keck Graduate Institute
Renata Ferrarotto
The University of Texas MD Anderson Cancer Center
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.